Cargando…

Antifungal prophylaxis in critically ill patients

Detalles Bibliográficos
Autores principales:	Silvestri, Luciano, Zandstra, Durk F, van Saene, Hendrick KF, Petros, Andy J, Thyagarajan, Sujatha, de la Cal, Miguel A, Thomann, Corrado
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481459/ https://www.ncbi.nlm.nih.gov/pubmed/18598370 http://dx.doi.org/10.1186/cc6906

Ejemplares similares

Withholding selective decontamination of the digestive tract from critically ill patients must now surely be ethically questionable given the vast evidence base
por: Zandstra, Durk F, et al.
Publicado: (2010)

Selective digestive decontamination is superior to selective oropharyngeal decontamination
por: Silvestri, Luciano, et al.
Publicado: (2011)

Probiotics do not significantly reduce nosocomial pneumonia
por: Silvestri, Luciano, et al.
Publicado: (2012)

Selective digestive decontamination saves lives whilst preventing resistance
por: Silvestri, Luciano, et al.
Publicado: (2015)

Selective decontamination of the digestive tract: selectivity is not required
por: Zandstra, D. F., et al.
Publicado: (2010)

Enteral feeding in the critically ill: comparison between the supine and prone positions: a prospective crossover study in mechanically ventilated patients
por: van der Voort, Peter HJ, et al.
Publicado: (2001)

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
por: Hatzl, Stefan, et al.
Publicado: (2021)

Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021)

Antifungal stewardship in critically ill patients
por: De Pascale, Gennaro, et al.
Publicado: (2023)

Reply: Antifungal Prophylaxis
por: Pennington, Kelly M., et al.
Publicado: (2021)

Single-drug therapy or selective decontamination of the digestive tract as antifungal prophylaxis in critically ill patients: a systematic review
por: van Till, JW Olivier, et al.
Publicado: (2007)

Thrombo-prophylaxis in acutely ill medical and critically ill patients
por: Saigal, Saurabh, et al.
Publicado: (2014)

Prophylaxis and treatment of venous thromboembolism in the critically ill
por: Adriance, Sarah M, et al.
Publicado: (2013)

Antifungal Prophylaxis in Immunocompromised Patients
por: Vazquez, Lourdes
Publicado: (2016)

Presence of tobramycin in blood and urine during selective decontamination of the digestive tract in critically ill patients, a prospective cohort study
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Stress ulcer prophylaxis in critically ill poisoned patients
por: Mehrpour, Omid, et al.
Publicado: (2012)

Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness
por: Cowley, NJ, et al.
Publicado: (2015)

Early steroid therapy for patients with H1N1 influenza A virus infection
por: Petros, A. J., et al.
Publicado: (2011)

Selective decontamination of the digestive tract: an update of the evidence
por: Silvestri, L, et al.
Publicado: (2012)

Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
por: Lyster, Haifa, et al.
Publicado: (2023)

Micafungin as antifungal prophylaxis in non-transplanted haemotological patients
por: Villaescusa, Teresa, et al.
Publicado: (2020)

Bench-to-bedside review: Sepsis is a disease of the microcirculation
por: Spronk, Peter E, et al.
Publicado: (2004)

Factors predicting prolonged empirical antifungal treatment in critically ill patients
por: Zein, Mohamed, et al.
Publicado: (2014)

Haloperidol prophylaxis in critically ill patients with a high risk for delirium
por: van den Boogaard, Mark, et al.
Publicado: (2013)

Venous Thromboembolism in Critically Ill Cirrhotic Patients: Practices of Prophylaxis and Incidence
por: Al-Dorzi, Hasan M., et al.
Publicado: (2013)

Weighing risks and benefits of stress ulcer prophylaxis in critically ill patients
por: Chanpura, Trupesh, et al.
Publicado: (2012)

Potential benefits of vitamin D for sepsis prophylaxis in critical ill patients
por: Guan, Jianbin, et al.
Publicado: (2023)

Empirical antifungal treatment in the critically ill patients: how does it impact on the outcome?
por: Bruyère, R, et al.
Publicado: (2012)

Current evidence of antifungal prophylaxis and therapy in pediatric patients
por: Giacchino, Mareva, et al.
Publicado: (2011)

Clinical practice update of antifungal prophylaxis in immunocompromised children
por: Ramos, José Tomás, et al.
Publicado: (2019)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?
por: Perreault, Sarah, et al.
Publicado: (2023)

Transport of critically ill COVID-19 patients
por: Yousuf, Beena, et al.
Publicado: (2020)

Efficacy and safety of enoxaparin as deep vein thrombosis prophylaxis in critically ill patients
por: Al-Hubail, R, et al.
Publicado: (2012)

Analysis of the impact of secondary prophylaxis on Clostridioides difficile recurrence in critically ill adults
por: Connor, Kathryn A, et al.
Publicado: (2020)

Pharmaceutical Venous Thrombosis Prophylaxis in Critically Ill Traumatic Brain Injury Patients
por: Huijben, Jilske A., et al.
Publicado: (2022)

When is the 'golden time' to apply the SOFA score in critically ill patients?
por: Sogayar, ACB, et al.
Publicado: (2003)

Need for expanded Candida Score for empiric antifungal use in medically critically ill patients?
por: Laine, Melanie E., et al.
Publicado: (2019)

Anticipatory Antifungal Treatment in Critically Ill Patients with SARS-CoV-2 Pneumonia
por: Estella, Ángel, et al.
Publicado: (2023)

Economic considerations of antifungal prophylaxis in patients undergoing surgical procedures
por: Cataldo, Maria Adriana, et al.
Publicado: (2011)

Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants
por: Takahashi, Daijiro, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_c92jtu4ndenvv03p354473ofh9